About this Research Topic
Recent research has unveiled a complex interplay of High-Density Lipoprotein (HDL)-related factors influencing cardiovascular health. This topic aims to provide an overview of the multifaceted roles of HDL in CVD, delving into its mechanisms of action, clinical relevance, and therapeutic implications such as:
-The role of HDL subfractions in predicting cardiovascular risk, biomarkers of HDL functionality as predictors of metabolic syndrome progression and cardiovascular risk,
-Changes in HDL levels, subclasses, and functionality over time and their association with cardiovascular events
-Effects of lipid-lowering medications (e.g., statins, PCSK9 inhibitors, fibrates) on HDL metabolism, composition, and functionality in individuals with CVD.
-The role of HDL subfractions in predicting cardiovascular risk, biomarkers of HDL functionality as predictors of metabolic syndrome progression and cardiovascular risk,
-Changes in HDL levels, subclasses, and functionality over time and their association with cardiovascular events
-Effects of lipid-lowering medications (e.g., statins, PCSK9 inhibitors, fibrates) on HDL metabolism, composition, and functionality in individuals with CVD.
Keywords: HDL
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
